Condition
Embryonal Rhabdomyosarcoma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Embryonal Rhabdomyosarcoma clinical trials that are recruiting, at sites in 4 countries (most in United States (2), Australia (1), Canada (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 4Countries
All recruiting trials (2)
-
Chemotherapy for very low-risk and low-risk rhabdomyosarcoma
This study is testing a new chemotherapy plan for patients with very low-risk and low-risk rhabdomyosarcoma to see if it can keep treatment effective while making it easier on them.
-
Registry for rare lung tumors and DICER1-related conditions
This study is collecting information about rare lung tumors in children, like pleuropulmonary blastoma, to help doctors understand how these conditions develop and how to treat them better.
Related topics
Quick answers
How many Embryonal Rhabdomyosarcoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), Australia (1 trial), Canada (1 trial), New Zealand (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.